古遂布(Drynaria fortunei J. Smith)通过 NLRP3/GSDMD/CASPASE-1 抑制热蛋白沉积,从而预防卵巢切除大鼠的骨质疏松症

Hui su , Jun Dong , Luyao Liu , Zechen Yan , Rujie Zhuang , Guangxin Huang , Haipeng Xue , Zhanwang Xu , Yu Pan
{"title":"古遂布(Drynaria fortunei J. Smith)通过 NLRP3/GSDMD/CASPASE-1 抑制热蛋白沉积,从而预防卵巢切除大鼠的骨质疏松症","authors":"Hui su ,&nbsp;Jun Dong ,&nbsp;Luyao Liu ,&nbsp;Zechen Yan ,&nbsp;Rujie Zhuang ,&nbsp;Guangxin Huang ,&nbsp;Haipeng Xue ,&nbsp;Zhanwang Xu ,&nbsp;Yu Pan","doi":"10.1016/j.prmcm.2024.100544","DOIUrl":null,"url":null,"abstract":"<div><div>Traditional Chinese medicine Gu Sui Bu (<em>Drynaria fortunei J. Smith</em>), has the effect of tonifying the kidneys and strengthening bone. There are many modern studies on the anti-osteoporosis pharmacological mechanism of Gu Sui Bu (<em>Drynaria fortunei J. Smith</em>) but no reports on the pharmacological mechanism of Gu Sui Bu (<em>Drynaria fortunei J. Smith</em>) improving cell pyroptosis and anti-osteoporosis have been found.</div></div><div><h3>Aim</h3><div>This study aims to verify the changes in cellular standard indicators in postmenopausal osteoporosis, thereby revealing the participating mechanism of pyroptosis and the intervention effect of Gu Sui Bu (<em>Drynaria fortunei J. Smith)</em> .</div></div><div><h3>Methods</h3><div>Gu Sui Bu (<em>Drynaria fortunei J. Smith</em>) subjected to UHPLC-Q-Orbitrap-MS/MS analysis, and the OVX rat model was constructed in vivo as the research object. It was divided into sham operation group (SHAM), ovariectomized osteoporosis model group (OVX) and Gu Sui Bu (<em>Drynaria fortunei J. Smith</em>) group (TFRD-L, TFRD-H). After 3 months of modeling, the medication group was treated with Gu Sui Bu (<em>Drynaria fortunei J. Smith</em>) and the samples were collected after 12 weeks of intervention. ELISA was used to detect the levels of Caspase-1, NLRP3, GSDMD, IL-1β, and IL-18 in rat serum; the right femur was taken for Micro-CT large bone microstructure scanning and femoral BMD detection; the femur was subjected to rat histopathology HE, TRAP staining; immunohistochemistry and immunofluorescence staining of rat histopathology were performed. WB and PCR were used to observe the expression of Osteoblasts and pyroptosis-related indicators Caspase-1, NLRP3, GSDMD and RUNX2, IL-1β, and IL-18.</div></div><div><h3>Results</h3><div>UHPLC-Q-Orbitrap-MS/MS analysis the main compounds in Gu Sui Bu (<em>Drynaria fortunei J. Smith)</em> samples were identified. These 9 chemical components are Palmitic acid, Fisetin, Caffeic acid, Naringin, Rutin, Uridine, Cafestol, Astilbin . Rat Micro-CT, The results of HE staining and TRAP showed that compared with the rats in the OVX group, the number of bone trabeculae in the rats in the <em>Gu Sui Bu (Drynaria fortunei J. Smith)</em> medication group (TFRD-L, TFRD-H) increased, became wider and thicker, and the bone density increased. Continuity increases and bone lacunae decrease. Rat serum ELISA, femoral tissue immunohistochemistry, immunofluorescence staining and WB, PCR showed that compared with the OVX group, Caspase-1, NLRP3, The expression levels of GSDMD and inflammation were reduced (p&lt;0.05), and the expression of osteogenic marker RUNX2 was reduced and increased (p&lt;0.05).</div></div><div><h3>Conclusion</h3><div>The traditional Chinese medicine Gu Sui Bu (<em>Drynaria fortunei J. Smith)</em> can improve the bone density of ovariectomized osteoporosis model rats and significantly enhance the bone microstructure. At the same time, it reduced the expression of pyroptosis markers Caspase-1, NLRP3, and GSDMD in vivo, confirming that <em>Gu Sui Bu (Drynaria fortunei J. Smith)</em> may play an anti-osteoporosis effect through the NLRP3/GSDMD/Caspase-1 pathway.</div></div>","PeriodicalId":101013,"journal":{"name":"Pharmacological Research - Modern Chinese Medicine","volume":"13 ","pages":"Article 100544"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Gu Sui Bu (Drynaria fortunei J. Smith) prevents osteoporosis in ovariectomized rats by inhibiting pyroptosis through NLRP3/GSDMD/CASPASE-1\",\"authors\":\"Hui su ,&nbsp;Jun Dong ,&nbsp;Luyao Liu ,&nbsp;Zechen Yan ,&nbsp;Rujie Zhuang ,&nbsp;Guangxin Huang ,&nbsp;Haipeng Xue ,&nbsp;Zhanwang Xu ,&nbsp;Yu Pan\",\"doi\":\"10.1016/j.prmcm.2024.100544\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Traditional Chinese medicine Gu Sui Bu (<em>Drynaria fortunei J. Smith</em>), has the effect of tonifying the kidneys and strengthening bone. There are many modern studies on the anti-osteoporosis pharmacological mechanism of Gu Sui Bu (<em>Drynaria fortunei J. Smith</em>) but no reports on the pharmacological mechanism of Gu Sui Bu (<em>Drynaria fortunei J. Smith</em>) improving cell pyroptosis and anti-osteoporosis have been found.</div></div><div><h3>Aim</h3><div>This study aims to verify the changes in cellular standard indicators in postmenopausal osteoporosis, thereby revealing the participating mechanism of pyroptosis and the intervention effect of Gu Sui Bu (<em>Drynaria fortunei J. Smith)</em> .</div></div><div><h3>Methods</h3><div>Gu Sui Bu (<em>Drynaria fortunei J. Smith</em>) subjected to UHPLC-Q-Orbitrap-MS/MS analysis, and the OVX rat model was constructed in vivo as the research object. It was divided into sham operation group (SHAM), ovariectomized osteoporosis model group (OVX) and Gu Sui Bu (<em>Drynaria fortunei J. Smith</em>) group (TFRD-L, TFRD-H). After 3 months of modeling, the medication group was treated with Gu Sui Bu (<em>Drynaria fortunei J. Smith</em>) and the samples were collected after 12 weeks of intervention. ELISA was used to detect the levels of Caspase-1, NLRP3, GSDMD, IL-1β, and IL-18 in rat serum; the right femur was taken for Micro-CT large bone microstructure scanning and femoral BMD detection; the femur was subjected to rat histopathology HE, TRAP staining; immunohistochemistry and immunofluorescence staining of rat histopathology were performed. WB and PCR were used to observe the expression of Osteoblasts and pyroptosis-related indicators Caspase-1, NLRP3, GSDMD and RUNX2, IL-1β, and IL-18.</div></div><div><h3>Results</h3><div>UHPLC-Q-Orbitrap-MS/MS analysis the main compounds in Gu Sui Bu (<em>Drynaria fortunei J. Smith)</em> samples were identified. These 9 chemical components are Palmitic acid, Fisetin, Caffeic acid, Naringin, Rutin, Uridine, Cafestol, Astilbin . Rat Micro-CT, The results of HE staining and TRAP showed that compared with the rats in the OVX group, the number of bone trabeculae in the rats in the <em>Gu Sui Bu (Drynaria fortunei J. Smith)</em> medication group (TFRD-L, TFRD-H) increased, became wider and thicker, and the bone density increased. Continuity increases and bone lacunae decrease. Rat serum ELISA, femoral tissue immunohistochemistry, immunofluorescence staining and WB, PCR showed that compared with the OVX group, Caspase-1, NLRP3, The expression levels of GSDMD and inflammation were reduced (p&lt;0.05), and the expression of osteogenic marker RUNX2 was reduced and increased (p&lt;0.05).</div></div><div><h3>Conclusion</h3><div>The traditional Chinese medicine Gu Sui Bu (<em>Drynaria fortunei J. Smith)</em> can improve the bone density of ovariectomized osteoporosis model rats and significantly enhance the bone microstructure. At the same time, it reduced the expression of pyroptosis markers Caspase-1, NLRP3, and GSDMD in vivo, confirming that <em>Gu Sui Bu (Drynaria fortunei J. Smith)</em> may play an anti-osteoporosis effect through the NLRP3/GSDMD/Caspase-1 pathway.</div></div>\",\"PeriodicalId\":101013,\"journal\":{\"name\":\"Pharmacological Research - Modern Chinese Medicine\",\"volume\":\"13 \",\"pages\":\"Article 100544\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-11-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmacological Research - Modern Chinese Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2667142524001866\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacological Research - Modern Chinese Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667142524001866","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

中药古遂布(Drynaria fortunei J. Smith)具有补肾壮骨的功效。现代有许多关于归脾汤抗骨质疏松药理机制的研究,但尚未发现归脾汤改善细胞热解和抗骨质疏松药理机制的报道。本研究旨在验证绝经后骨质疏松症细胞标准指标的变化,从而揭示古遂布参与骨质疏松的机制及其干预作用。 方法将古遂布(Drynaria fortunei J. Smith)进行超高效液相色谱-Q-Orbitrap-MS/MS分析,在体内构建OVX大鼠模型作为研究对象。该模型分为假手术组(SHAM)、卵巢切除骨质疏松症模型组(OVX)和古遂布(Drynaria fortunei J. Smith)组(TFRD-L、TFRD-H)。建模 3 个月后,药物组接受顾遂布(Drynaria fortunei J. Smith)治疗,干预 12 周后收集样本。采用ELISA法检测大鼠血清中Caspase-1、NLRP3、GSDMD、IL-1β和IL-18的水平;取右股骨进行Micro-CT大骨显微结构扫描和股骨BMD检测;对大鼠股骨进行组织病理学HE、TRAP染色;对大鼠组织病理学进行免疫组化和免疫荧光染色。结果UHPLC-Q-Orbitrap-MS/MS分析确定了古遂布(Drynaria fortunei J. Smith)样品中的主要化合物。这 9 种化学成分分别是棕榈酸、鱼腥苷、咖啡酸、柚皮苷、芦丁、尿苷、咖啡酚、黄芪苷。大鼠显微 CT:HE 染色和 TRAP 结果显示,与卵巢功能缺失组大鼠相比,服用古遂布(Drynaria fortunei J. Smith)药物组(TFRD-L、TFRD-H)大鼠的骨小梁数量增加,骨小梁变宽、变粗,骨密度增加。连续性增加,骨裂减少。大鼠血清ELISA、股骨组织免疫组化、免疫荧光染色和WB、PCR结果显示,与OVX组相比,Caspase-1、NLRP3、GSDMD和炎症的表达水平降低(p<0.05),成骨标志物 RUNX2 的表达减少和增加(p<0.05)。 结论中药古遂布(Drynaria fortunei J. Smith)能提高卵巢切除骨质疏松症模型大鼠的骨密度,显著增强骨的微结构。同时,它还能降低体内Caspase-1、NLRP3和GSDMD的表达,证实古遂布可通过NLRP3/GSDMD/Caspase-1途径发挥抗骨质疏松症的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Gu Sui Bu (Drynaria fortunei J. Smith) prevents osteoporosis in ovariectomized rats by inhibiting pyroptosis through NLRP3/GSDMD/CASPASE-1
Traditional Chinese medicine Gu Sui Bu (Drynaria fortunei J. Smith), has the effect of tonifying the kidneys and strengthening bone. There are many modern studies on the anti-osteoporosis pharmacological mechanism of Gu Sui Bu (Drynaria fortunei J. Smith) but no reports on the pharmacological mechanism of Gu Sui Bu (Drynaria fortunei J. Smith) improving cell pyroptosis and anti-osteoporosis have been found.

Aim

This study aims to verify the changes in cellular standard indicators in postmenopausal osteoporosis, thereby revealing the participating mechanism of pyroptosis and the intervention effect of Gu Sui Bu (Drynaria fortunei J. Smith) .

Methods

Gu Sui Bu (Drynaria fortunei J. Smith) subjected to UHPLC-Q-Orbitrap-MS/MS analysis, and the OVX rat model was constructed in vivo as the research object. It was divided into sham operation group (SHAM), ovariectomized osteoporosis model group (OVX) and Gu Sui Bu (Drynaria fortunei J. Smith) group (TFRD-L, TFRD-H). After 3 months of modeling, the medication group was treated with Gu Sui Bu (Drynaria fortunei J. Smith) and the samples were collected after 12 weeks of intervention. ELISA was used to detect the levels of Caspase-1, NLRP3, GSDMD, IL-1β, and IL-18 in rat serum; the right femur was taken for Micro-CT large bone microstructure scanning and femoral BMD detection; the femur was subjected to rat histopathology HE, TRAP staining; immunohistochemistry and immunofluorescence staining of rat histopathology were performed. WB and PCR were used to observe the expression of Osteoblasts and pyroptosis-related indicators Caspase-1, NLRP3, GSDMD and RUNX2, IL-1β, and IL-18.

Results

UHPLC-Q-Orbitrap-MS/MS analysis the main compounds in Gu Sui Bu (Drynaria fortunei J. Smith) samples were identified. These 9 chemical components are Palmitic acid, Fisetin, Caffeic acid, Naringin, Rutin, Uridine, Cafestol, Astilbin . Rat Micro-CT, The results of HE staining and TRAP showed that compared with the rats in the OVX group, the number of bone trabeculae in the rats in the Gu Sui Bu (Drynaria fortunei J. Smith) medication group (TFRD-L, TFRD-H) increased, became wider and thicker, and the bone density increased. Continuity increases and bone lacunae decrease. Rat serum ELISA, femoral tissue immunohistochemistry, immunofluorescence staining and WB, PCR showed that compared with the OVX group, Caspase-1, NLRP3, The expression levels of GSDMD and inflammation were reduced (p<0.05), and the expression of osteogenic marker RUNX2 was reduced and increased (p<0.05).

Conclusion

The traditional Chinese medicine Gu Sui Bu (Drynaria fortunei J. Smith) can improve the bone density of ovariectomized osteoporosis model rats and significantly enhance the bone microstructure. At the same time, it reduced the expression of pyroptosis markers Caspase-1, NLRP3, and GSDMD in vivo, confirming that Gu Sui Bu (Drynaria fortunei J. Smith) may play an anti-osteoporosis effect through the NLRP3/GSDMD/Caspase-1 pathway.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.60
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信